Mihael Polymeropoulos

Mihael Polymeropoulos

Chief Executive Officer at VANDA PHARMACEUTICALS INC.

Net worth: 8 M $ as of 2024-04-29

64 year
Health Technology
Consumer Services
Government

Network origin in Mihael Polymeropoulos first degree

EntityEntity typeIndustry
Public Company Pharmaceuticals: Major 54
Public Company Pharmaceuticals: Major 39
3
Government General Government 3

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Mihael Polymeropoulos via their personal network

CompanySectorRelated peopleMain position
Miscellaneous Commercial Services

Kleanthis Xanthopoulos

H. Watkins

Deborah Dunsire

Vin Milano Milano

Howard H. Pien

Ludwig Hantson

Robert Repella

Royston Glasspool

Director/Board Member

Chairman

Corporate Secretary

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Paul Herrling

Argeris Karabelas

Reinhard Ambros

Fredrik Ollila

Peter Maag

Harry Werner Kirsch

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

GSK PLC Pharmaceuticals: Major

Howard H. Pien

Argeris Karabelas

James New

Jinzi Wu

Albert W. Gianchetti

Corporate Officer/Principal

Private Equity Analyst

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

George Gunn

Paul Herrling

Jürgen Brokatzky-Geiger

Peter Maag

Harry Werner Kirsch

Director/Board Member

Chief Tech/Sci/R&D Officer

Director/Board Member

Corporate Officer/Principal

Director/Board Member

BAXTER INTERNATIONAL INC. Medical Specialties

Wayne T. Hockmeyer

Peter Nicklin

Ludwig Hantson

Royston Glasspool

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Georgetown University College/University

Jan Smilek

John Joseph Feeney

Phaedra Chrousos

Kim Wijkstrom

Masters Business Admin

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Harvard Medical School College/University

James Tananbaum

Enrique Carrazana

Robert Nussbaum

Brian Hubbard

Doctorate Degree

Doctorate Degree

Doctorate Degree

Graduate Degree

Miscellaneous Commercial Services

Vin Milano Milano

Michael Cola

Brian Halak

Robert Repella

Chairman

Director/Board Member

Director/Board Member

Director/Board Member

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

James New

Peter Nicklin

Antony Mattessich

Thomas Gibbs

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

College/University

William George

Chip Clark

Srikant T. Madhav Datar

Paolo Baroldi

Masters Business Admin

Undergraduate Degree

Corporate Officer/Principal

Masters Business Admin

Pharmaceuticals: Major

Ulrich Lehner

Thomas Ebeling

Jinzi Wu

Ludwig Hantson

Director/Board Member

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

The Trustees of Columbia University in The City of New York College/University

Frank Palantoni

Antony Mattessich

Scott Howell

Masters Business Admin

Graduate Degree

Graduate Degree

University of Maryland College/University

Stephanie R. Irish

Kevin Smith

Todd Horich

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

BAXALTA INC Biotechnology

Wayne T. Hockmeyer

Ludwig Hantson

Royston Glasspool

Chairman

Chief Executive Officer

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

James Tananbaum

Howard H. Pien

Steven Kelmar

Corporate Officer/Principal

Corporate Officer/Principal

Public Communications Contact

University of Basel College/University

Paul Herrling

Rolf M. Zinkernagel

Philippe Weigerstorfer

Director/Board Member

Doctorate Degree

Graduate Degree

Harvard Business School College/University

James Tananbaum

William George

Srikant T. Madhav Datar

Masters Business Admin

Corporate Officer/Principal

Corporate Officer/Principal

University of Bocconi College/University

Norman Walker

Giancarlo Mocchi

Mauro Ghilardi

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

International Institute for Management Development College/University

William George

Karen Hübscher

Paul Choffat

Corporate Officer/Principal

Masters Business Admin

Graduate Degree

Investment Managers

Chip Clark

Argeris Karabelas

David Ramsay

Private Equity Investor

Private Equity Investor

Founder

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Deborah Dunsire

Sarah Boyce

Ludwig Hantson

Director/Board Member

Corporate Officer/Principal

Chief Executive Officer

SUPERNUS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Paolo Baroldi

James Kelly

Todd Horich

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

Sales & Marketing

PFIZER, INC. Pharmaceuticals: Major

Pierre F. Dodion

James New

Krishan K. Arora

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

The Pennsylvania State University College/University

Richard Dugan

Steven Kelmar

Joseph A. Sliman

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Peter Maag

Harry Werner Kirsch

Thomas Gibbs

President

Director/Board Member

Sales & Marketing

Columbia Business School College/University

James New

Phaedra Chrousos

Jose Carmona

Masters Business Admin

Masters Business Admin

Masters Business Admin

The Wharton School of the University of Pennsylvania College/University

Ken Bate

Chip Clark

Thomas Gibbs

Masters Business Admin

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Deborah Dunsire

Howard H. Pien

Krishan K. Arora

Director/Board Member

Director/Board Member

Chairman

Miscellaneous Commercial Services

Paul Herrling

Francis S. Collins

Director/Board Member

Director/Board Member

Medical Specialties

H. Watkins

Argeris Karabelas

Chief Executive Officer

Chairman

The College of William & Mary College/University

H. Watkins

Brian Hubbard

Undergraduate Degree

Undergraduate Degree

ABBOTT LABORATORIES Medical Specialties

H. Watkins

Howard H. Pien

Corporate Officer/Principal

Corporate Officer/Principal

The University of Chicago Booth School of Business College/University

H. Watkins

Steven Shallcross

Masters Business Admin

Masters Business Admin

University of Zurich College/University

Paul Herrling

Rolf M. Zinkernagel

Doctorate Degree

Director/Board Member

Swiss Federal Institute of Technology College/University

Paul Herrling

Karen Hübscher

Corporate Officer/Principal

Doctorate Degree

Iowa State University College/University

Krishan K. Arora

Aranthan Jones

Doctorate Degree

Undergraduate Degree

Pharmaceuticals: Generic

Paul Herrling

Karen Hübscher

Chief Tech/Sci/R&D Officer

Director/Board Member

SANOFI Biotechnology

Krishan K. Arora

Dario Eklund

Corporate Officer/Principal

Corporate Officer/Principal

Rutgers State University of New Jersey College/University

Deepak Shripad Phadke

Robert Repella

Doctorate Degree

Undergraduate Degree

Biotechnology

Wayne T. Hockmeyer

James Kelly

Chief Executive Officer

Comptroller/Controller/Auditor

IDENIX PHARMACEUTICALS INC Pharmaceuticals: Major

Wayne T. Hockmeyer

Thomas Ebeling

Director/Board Member

Director/Board Member

Medical Specialties

William George

Steven Kelmar

Chief Executive Officer

Public Communications Contact

Miscellaneous Commercial Services

Paul Herrling

Harry Werner Kirsch

Corporate Officer/Principal

Director/Board Member

College/University

James Kelly

Aranthan Jones

Masters Business Admin

Masters Business Admin

JOHNSON & JOHNSON Pharmaceuticals: Major

Bruce F. Fleming

Ludwig Hantson

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Ken Bate

Deborah Dunsire

Director of Finance/CFO

Chief Executive Officer

Statistics

International

United States 40
Switzerland 8
France 3
United Kingdom 2
Italy 2

Sectoral

Health Technology 27
Consumer Services 20
Commercial Services 5
Finance 2

Operational

Director/Board Member 452
Corporate Officer/Principal 249
Independent Dir/Board Member 114
Chief Executive Officer 95
Chairman 88
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW